MLSS vs. INGN, LAKE, CLGN, APT, NTRB, COCH, RBOT, LFWD, POAI, and HSCS
Should you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT), Nutriband (NTRB), Envoy Medical (COCH), Vicarious Surgical (RBOT), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and Heart Test Laboratories (HSCS). These companies are all part of the "surgical appliances & supplies" industry.
Inogen (NASDAQ:INGN) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk, institutional ownership and community ranking.
89.9% of Inogen shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 1.0% of Inogen shares are owned by company insiders. Comparatively, 25.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Inogen had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Inogen and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 1.43 beat Inogen's score of 0.00 indicating that Inogen is being referred to more favorably in the media.
Inogen has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.
Inogen presently has a consensus target price of $7.00, suggesting a potential downside of 15.66%. Given Milestone Scientific's higher possible upside, analysts clearly believe Inogen is more favorable than Milestone Scientific.
Inogen has a net margin of -30.07% compared to Inogen's net margin of -74.50%. Milestone Scientific's return on equity of -42.87% beat Inogen's return on equity.
Inogen received 386 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 70.44% of users gave Inogen an outperform vote while only 0.00% of users gave Milestone Scientific an outperform vote.
Milestone Scientific has lower revenue, but higher earnings than Inogen. Milestone Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.
Summary
Inogen beats Milestone Scientific on 13 of the 17 factors compared between the two stocks.
Get Milestone Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Milestone Scientific Competitors List
Related Companies and Tools
